Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (10)
Leukemia (4)
Nature Cancer (2)
Blood Cancer Journal (1)
Nature Communications (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (13)
Reviews (3)
Amendments and Corrections (1)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biotechnology
Cancer
Diseases
Drug discovery
Health care
Immunology
Medical research
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–18 of 18 results

Advanced filters: Author: Gandhi Damaj Clear advanced filters

Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up

Jerome Paillassa
Edouard Cornet
Xavier Troussard
ResearchOpen Access27 May 2020
Blood Cancer Journal

Volume: 10, P: 1-12
Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets

Extranodal NK/T-cell lymphoma (ENKTCL) is an aggressive Epstein-Barr virus (EBV)-related neoplasm. Here the authors report a genetically engineered mouse model harboring NK-cellspecific Trp53 deletion to model ENKTCL in mice

Junji Koya
Tomohiko Tanigawa
Keisuke Kataoka
ResearchOpen Access22 Oct 2024
Nature Communications

Volume: 15, P: 1-15
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT

Toby A. Eyre
Sophie Caillard
Silvia Montoto
ResearchOpen Access16 Apr 2021
Bone Marrow Transplantation

Volume: 56, P: 2118-2124
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study

Domitille Costes-Tertrais
Thomas Hueso
Steven Le Gouill
Research11 Feb 2022
Bone Marrow Transplantation

Volume: 57, P: 627-632
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Kim and colleagues perform a phase 2 clinical trial (ELM-2) of odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma and report on the primary analyses of the efficacy and safety profile.

Won Seog Kim
Tae Min Kim
Umar Farooq
ResearchOpen Access17 Mar 2025
Nature Cancer

Volume: 6, P: 528-539
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study

Adam Mainguy
Carole Soussain
Caroline Houillier
ResearchOpen Access19 Nov 2024
Bone Marrow Transplantation

Volume: 60, P: 297-304
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee

Gandhi Damaj
Adèle de Masson
Norbert Schmitz
ReviewsOpen Access01 Oct 2025
Bone Marrow Transplantation

Volume: 60, P: 1565-1573
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network

Laurence Schenone
Caroline Houillier
Thomas Gastinne
Research14 Apr 2022
Bone Marrow Transplantation

Volume: 57, P: 966-974
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

Thomas Hueso
Thomas Gastinne
Gandhi Damaj
Research17 Jan 2020
Bone Marrow Transplantation

Volume: 55, P: 1076-1084
Author Correction: Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial

Won Seog Kim
Tae Min Kim
Umar Farooq
Amendments and CorrectionsOpen Access16 Apr 2025
Nature Cancer

Volume: 6, P: 907
Acute myeloid leukemia after CAR T-cell therapy: role of pre-existing clonal hematopoiesis and inflammation in leukemogenesis

Paul Chauvet
Cynthia Saade
Ibrahim Yakoub-Agha
Correspondence21 Aug 2025
Bone Marrow Transplantation

Volume: 60, P: 1529-1532
Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Nicolas Gazeau
David Beauvais
Pierre Sesques
ResearchOpen Access24 Apr 2025
Leukemia

Volume: 39, P: 1714-1722
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

Michael Wang
Simon Rule
Monika Długosz-Danecka
ResearchOpen Access26 Sept 2019
Leukemia

Volume: 33, P: 2762-2766
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

Sebastian Giebel
Myriam Labopin
Depei Wu
Research05 Sept 2020
Bone Marrow Transplantation

Volume: 56, P: 481-491
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Benoit Tessoulin
David Chiron
Steven Le Gouill
Research03 Mar 2021
Bone Marrow Transplantation

Volume: 56, P: 1700-1709
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Rémi Letestu
Abdelmalek Dahmani
Henry Jardel
Research15 Sept 2020
Leukemia

Volume: 35, P: 1597-1609
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

Donal P. McLornan
Tomasz Czerw
Deepti H. Radia
Reviews12 Mar 2024
Leukemia

Volume: 38, P: 699-711
Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review

G Damaj
J Cornillon
E Gyan
Reviews23 Jan 2017
Bone Marrow Transplantation

Volume: 52, P: 941-949